Skip to main content
OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.950
+0.060 (3.17%)
At close: Mar 9, 2026, 4:00 PM EDT
1.980
+0.030 (1.54%)
After-hours: Mar 9, 2026, 5:09 PM EDT

OmniAb Revenue

In the year 2025, OmniAb had annual revenue of $18.67M, down -29.27%. OmniAb had revenue of $8.38M in the quarter ending December 31, 2025, a decrease of -22.47%.

Revenue (ttm)
$18.67M
Revenue Growth
-29.27%
P/S Ratio
14.74
Revenue / Employee
$163,737
Employees
114
Market Cap
282.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202518.67M-7.73M-29.27%
Dec 31, 202426.39M-7.77M-22.75%
Dec 31, 202334.16M-24.91M-42.17%
Dec 31, 202259.08M24.33M70.02%
Dec 31, 202134.75M11.48M49.34%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus Oncology 277.73M
Cellectis 82.55M
Ovid Therapeutics 6.61M
AC Immune 5.48M
Orchestra BioMed Holdings 2.82M
Silence Therapeutics 559.00K
Abeona Therapeutics 400.00K
Revenue Rankings

OABI News

More News